Precision brain health. To help prevent, diagnose and personalize treatment for brain disorders.
New York, USA
Joined April 2018
- Tweets427
- Following711
- Followers227
- Likes1.6K
Pinned Tweet
Thanks Fox Business for featuring a short film, that will air nationally at about ViewMind Inc.#healthcare #technology #neurology #neuroscience #neurology #alzheimersdisease #MultipleSclerosis #biomarkers #neurodegenerativediseases #neurologicaldisorders #endalz
🎉 ViewMind has graduated from the AgeTech Collaborative™ from AARP Accelerator Program!
We’re proud to be an AgeTech Collaborative™ Portfolio Company advancing innovation in cognitive health and longevity.
#agetech #AgeTechCollaborative #longevity #neurotech #digitalhealth
Thank you to everyone who visited our stand and experienced ViewMind’s technology firsthand at the @alzassociation ’s International Conference in Toronto.
linkedin.com/feed/update/urn…
#AAIC2025 #BrainHealth #Alzheimers #ClinicalTrials #DigitalBiomarkers #Innovation
We’ve just presented one of our new studies at AAIC 2025: “Cognitive and Motor Behaviors in Alzheimer’s, Parkinson’s, and Healthy Individuals.”
Visit us at Booth #1437 to learn more about our cutting-edge cognitive assessment platform.
#AAIC2025
@alzassociation
We are here at AAIC 2025
📍 Booth #1437 | 27 to 29 July 2025 | Toronto, Canada
We’re proud to be presenting cutting-edge research and showcasing our patented cognitive assessment platform, ViewMind Atlas™.
@alzassociation #AAIC2025 #BrainHealth #Alzheimers #HealthTech
ViewMind Atlas™ is a non-invasive, eye-tracking-based digital tool that has the potential to support:
✔ Early detection of Alzheimer’s
✔ Cognitive endpoints in clinical trials
✔ Scalable integration into research and healthcare environments
ALZHEIMER’S DRUG DISCOVERY FOUNDATION’S DIAGNOSTICS ACCELERATOR (DXA) Invests $1.4M in ViewMind’s technology. einpresswire.com/article/780… via @ein_news
#BrainHealth #Alzheimers #NeurologicalDisorders #HealthTech #EyeTracking #InnovationInHealthcare #Biomarkers #PrecisionMedicine
As the year comes to a close, we want to take a moment to express our gratitude to our partners and supporters. Together, we advanced our mission of transforming brain health through innovative, data-driven solutions.
#BrainHealth #HealthInnovation #CognitiveHealth #ThankYou
We are pleased to share that Dr. Danilo Verge, @ViewMind_ 's Chief Medical Officer, presented to nearly 300 endocrinologists at the Intensive @cursodavidson 2024 in Miami.
#ViewMind #MedicalEducation #CognitiveHealth #Endocrinology #DiagnosticsInnovation
ViewMind’s non-invasive technology offers valuable insights that have the potential to also be relevant for endocrinologists. By detecting cognitive changes in cardiometabolic conditions, our solution has the potential to support earlier intervention and personalized care.
ViewMind is proud to announce its participation in the Bio-Hermes-002 study in collaboration with the Global Alzheimer’s Platform Foundation® (GAP).
#BioHermes002 #AlzheimersResearch #DiversityInResearch #DigitalBiomarkers #ViewMind #Cognitive
"In addition, ViewMind has developed a specialized assessment for Alzheimer’s disease. Initial results indicate high sensitivity and specificity to detect asymptomatic stages over 10 years before symptoms and amnestic MCI. ” said Mark Edwards, CEO & Co-founder of ViewMind Inc.
We are honored to announce that ViewMind Inc. has been named one of the three winners of the Accelerate UK 2024 competition!
We are thrilled to be joining the #AccelerateUK program and look forward to the opportunities it will bring.
#innovation #BrainHealth #Health #healthcare
A huge thank you to the #AccelerateUK team for this opportunity, and congratulations to all finalists